{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:30:18Z","timestamp":1789695018196,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012550","name":"National Research, Development and Innovation Fund of Hungary","doi-asserted-by":"publisher","award":["FK_18 and K_15"],"award-info":[{"award-number":["FK_18 and K_15"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cca.2019.10.010","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T19:41:46Z","timestamp":1572291706000},"page":"155-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis"],"prefix":"10.1016","volume":"500","author":[{"given":"Attila","family":"Enyedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Csongr\u00e1di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n T.","family":"Altorjay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerg\u0151 L.","family":"Beke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csongor","family":"V\u00e1radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enik\u0151 E.","family":"Enyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorina R.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emese","family":"B\u00e1nyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Kalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Kappelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Tak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Fagyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.10.010_b0005","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1080\/14656566.2016.1258061","article-title":"SarcoGEAS-SEMI study group, sarcoidosis: an update on current pharmacotherapy options and future directions","volume":"17","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.cca.2019.10.010_b0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on Sarcoidosis","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cca.2019.10.010_b0015","first-page":"1","article-title":"Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis","author":"Ramos-Casals","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.cca.2019.10.010_b0020","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1515\/cclm-2017-0837","article-title":"Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis","volume":"56","author":"Csongr\u00e1di","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0025","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.10.010_b0030","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/nar\/20.6.1433-a","article-title":"PCR detection of the insertion\/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)","volume":"20","author":"Rigat","year":"1992","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cca.2019.10.010_b0035","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJM199503163321103","article-title":"A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease","volume":"332","author":"Lindpaintner","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0040","doi-asserted-by":"crossref","first-page":"e93719","DOI":"10.1371\/journal.pone.0093719","article-title":"New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases","volume":"9","author":"Fagyas","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.10.010_b0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ppul.22749","article-title":"Duplication in CHIT1 gene and the risk for Aspergillus lung disease in CF patients","volume":"49","author":"Livnat","year":"2014","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.cca.2019.10.010_b0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/aje\/kwn359","article-title":"Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies","volume":"169","author":"Rodriguez","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cca.2019.10.010_b0055","unstructured":"Clinical and Laboratory Standards Institute (CLSI), Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory, CLSI document C28-A3c., 3rd Edition, 2010."},{"key":"10.1016\/j.cca.2019.10.010_b0060","unstructured":"J.W. Tukey, Exploratory Data Analysis, Pearson, 1977."},{"key":"10.1016\/j.cca.2019.10.010_b0065","series-title":"Evaluation of Diagnostic and Screening Tests: Validity and Reliability","author":"Kanchanaraksa","year":"2008"},{"key":"10.1016\/j.cca.2019.10.010_b0070","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/thx.51.8.777","article-title":"Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis","volume":"51","author":"Furuya","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.cca.2019.10.010_b0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0004563214529261","article-title":"Development of a high-resolution melting genotyping assay for the angiotensin I converting enzyme insertion\/deletion polymorphism and establishment of genotype-specific reference intervals in a Danish population","volume":"52","author":"Nissen","year":"2015","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2019.10.010_b0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rmed.2014.02.002","article-title":"Serial chitotriosidase measurements in sarcoidosis \u2013 Two to five year follow-up study","volume":"108","author":"Harlander","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2009.09.034","article-title":"Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis","volume":"411","author":"Boot","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.10.010_b0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/00365510701854975","article-title":"Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity","volume":"68","author":"Bargagli","year":"2008","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2019.10.010_b0095","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cca.2019.10.010_b0100","article-title":"The diagnosis of sarcoidosis","volume":"1","author":"Judson","year":"2019","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0105","first-page":"219","article-title":"Biomarkers in Sarcoidosis","author":"Baughman","year":"2019","journal-title":"Sarcoidosis."},{"key":"10.1016\/j.cca.2019.10.010_b0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(75)90395-2","article-title":"Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis","volume":"59","author":"Lieberman","year":"1975","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ccm.2008.03.004","article-title":"Markers of Inflammation in Sarcoidosis: Blood, Urine, BAL, Sputum, and Exhaled Gas","volume":"29","author":"Bargagli","year":"2008","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.cca.2019.10.010_b0120","article-title":"New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) II: Albumin Suppresses Angiotensin Converting Enzyme (ACE) Activity in Human","volume":"9","author":"Fagyas","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.cca.2019.10.010_b0125","article-title":"New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition","volume":"9","author":"Fagyas","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.cca.2019.10.010_b0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1755-5922.2010.00252.x","article-title":"Differences in Angiotensin Convertase Enzyme (ACE) Activity and Expression May Contribute to Shorter Event Free Period After Coronary Artery Bypass Graft Surgery","volume":"30","author":"Darag\u00f3","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.cca.2019.10.010_b0135","article-title":"New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) III: Endogenous Inhibition of Angiotensin Converting Enzyme (ACE) Provides Protection against Cardiovascular Diseases","volume":"9","author":"Fagyas","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.cca.2019.10.010_b0140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1445-5994.1999.tb00713.x","article-title":"Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity","volume":"29","author":"Stokes","year":"1999","journal-title":"Aust. N. Z. J. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0145","doi-asserted-by":"crossref","DOI":"10.2217\/bmm-2018-0252","article-title":"Predictive value of platelet-to-lymphocyte ratio in patients with sarcoidosis","author":"Yaln\u0131z","year":"2019","journal-title":"Biomark. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cca.2019.10.010_b0155","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/ajrccm\/139.4.1036","article-title":"Prolonged elevations of soluble interleukin-2 receptors in tuberculosis","volume":"139","author":"Brown","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.cca.2019.10.010_b0160","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-105-4-560","article-title":"The Human Interleukin-2 Receptor: Normal and Abnormal Expression in T Cells and in Leukemias Induced by the Human T-Lymphotropic Retroviruses","volume":"105","author":"Greene","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0165","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","article-title":"The soluble interleukin-2 receptor: biology, function, and clinical application","volume":"113","author":"Rubin","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archophthalmol.2011.52","article-title":"Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis","volume":"129","author":"Birnbaum","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.cca.2019.10.010_b0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12886-016-0194-4","article-title":"The serum angiotensin converting enzyme and lysozyme levels in patients with ocular involvement of autoimmune and infectious diseases","volume":"16","author":"Sahin","year":"2016","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.cca.2019.10.010_b0180","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjophthalmol-2014-306353","article-title":"Clinical features and diagnostic evaluation of 83 biopsy-proven sarcoid uveitis cases","volume":"99","author":"Febvay","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.cca.2019.10.010_b0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10384-006-0413-2","article-title":"Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients","volume":"51","author":"Kawaguchi","year":"2007","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.cca.2019.10.010_b0190","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1172\/JCI106387","article-title":"Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia","volume":"49","author":"Pruzanski","year":"1970","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.10.010_b0195","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum Amyloid A Regulates Granulomatous Inflammation in Sarcoidosis through Toll-like Receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cca.2019.10.010_b0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1465-9921-14-18","article-title":"Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients","volume":"14","author":"Zhang","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.cca.2019.10.010_b0205","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.10.010_b0210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rmed.2010.12.010","article-title":"Analysis of serum amyloid A in sarcoidosis patients","volume":"105","author":"Bargagli","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0215","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1378\/chest.09-1975","article-title":"Comparative evaluation of serum markers in pulmonary sarcoidosis","volume":"137","author":"Miyoshi","year":"2010","journal-title":"Chest."},{"key":"10.1016\/j.cca.2019.10.010_b0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/00365510410004092","article-title":"Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis","volume":"64","author":"Grosso","year":"2004","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2019.10.010_b0225","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/intimm\/dxh328","article-title":"Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity","volume":"17","author":"van Eijk","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cca.2019.10.010_b0230","first-page":"13","article-title":"Relation between clinical stage of sarcoidosis and serum values of angiotensin converting enzyme and beta2-microglobulin","volume":"4","author":"Selroos","year":"1987","journal-title":"Sarcoidosis."},{"key":"10.1016\/j.cca.2019.10.010_b0235","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.cca.2019.10.010_b0240","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/CVI.00337-10","article-title":"Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis","volume":"18","author":"Loza","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cca.2019.10.010_b0245","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2017.4771","article-title":"Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis","volume":"135","author":"Groen-Hakan","year":"2017","journal-title":"JAMA Ophthalmol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811932073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811932073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:49:41Z","timestamp":1757861381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811932073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":49,"alternative-id":["S000989811932073X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.10.010","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}